WRAP53 beta, survivin and p16(INK4a) expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer

Katharina Tiefenbock-Hansson, Aaro Haapaniemi, Lovisa Farnebo, Bjorn Palmgren, Jussi Tarkkanen, Marianne Farnebo, Eva Munck-Wikland, Antti Makitie, Stina Garvin, Karin Roberg

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalOncology Reports
Volume38
Issue number4
Pages (from-to)2062-2068
Number of pages7
ISSN1021-335X
DOIs
Publication statusPublished - Oct 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • head and neck cancer
  • radiotherapy
  • chemoradiotherapy
  • survival
  • recurrence
  • biomarker
  • WRAP53 beta
  • survivin
  • p16
  • SQUAMOUS-CELL CARCINOMA
  • HUMAN-PAPILLOMAVIRUS
  • CONCURRENT CHEMOTHERAPY
  • PROGNOSTIC-SIGNIFICANCE
  • ORGAN PRESERVATION
  • RADIATION-THERAPY
  • POSITIVE RESPONSE
  • RADIOTHERAPY
  • NUCLEAR
  • OVEREXPRESSION
  • 3122 Cancers

Cite this